Thomas G. O’Riordan named Editor-in-Chief of the Journal of Aerosol Medicine and Pulmonary Drug Delivery

The Journal of Aerosol Medicine and Pulmonary Drug Delivery, the official journal of the International Society for Aerosols in Medicine (ISAM), has announced that GSK VP US Medical and Therapy Head for Respiratory Thomas G. O’Riordan will take over as Editor-in-Chief as of March 1, 2022. His predecessor, Gerry Smaldone, announced in October 2021 that he would step down at the end of that year, and ISAM encouraged members to apply for the position.

O’Riordan commented, “I am honored to be selected as Editor-in-Chief with the opportunity to build on the great work of the founding Editor-in-Chief, Dr. Gerry Smaldone and the Associate Editor, Dr. Tim Corcoran. I look forward to working with the publisher, editorial board, and with many reviewers who generously devote their time to ensuring that the Journal publishes impactful high-quality research and to continuing close collaboration with the International Society for Aerosols in Medicine.”

The announcement added, “We warmly thank Dr. Smaldone for his decades of hard work and dedication to the publication and the field. We also express our gratitude to Tim Corcoran, PhD, for his outstanding work as Associate Editor since 2014.”